Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
JPM
since
auto-detected in 2 stories
44 days ago
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
10 months ago
JPMorgan Chase shares may have further to fall. This options trade makes money off the decline ○
Despite beating earnings expectations, JPM continues to exhibit technical weakness.
page 1 of 1